000650 仁和藥業
按盤價 
5.940 -0.070 (-1.165%)
5.940 -0.070 (-1.165%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.876 | 9.669 | 10.418 | 12.814 | 13.040 |
| 總資產報酬率 ROA (%) | 5.513 | 7.524 | 7.900 | 10.018 | 10.075 |
| 投入資產回報率 ROIC (%) | 6.694 | 9.272 | 9.899 | 12.388 | 12.825 | 邊際利潤分析 |
| 銷售毛利率 (%) | 37.647 | 37.122 | 36.617 | 37.975 | 39.224 |
| 營業利潤率 (%) | 21.770 | 17.858 | 18.498 | 21.008 | 20.610 |
| 息稅前利潤/營業總收入 (%) | 21.378 | 17.367 | 18.056 | 19.838 | 20.104 |
| 淨利潤/營業總收入 (%) | 16.343 | 12.508 | 13.808 | 16.206 | 15.763 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 81.579 | 109.815 | 99.102 | 95.101 | 92.450 |
| 價值變動淨收益/利潤總額(%) | 3.044 | 8.465 | 7.176 | 3.040 | 8.210 |
| 營業外收支淨額/利潤總額(%) | -0.371 | 0.025 | 0.029 | -0.243 | -1.481 | 償債能力分析 |
| 流動比率 (X) | 6.199 | 6.103 | 3.934 | 4.187 | 5.422 |
| 速動比率 (X) | 5.697 | 5.509 | 3.541 | 3.566 | 4.773 |
| 資產負債率 (%) | 10.324 | 10.614 | 15.888 | 14.201 | 0.115 |
| 帶息債務/全部投入資本 (%) | 2.517 | 1.513 | 5.261 | 3.552 | 2.609 |
| 股東權益/帶息債務 (%) | 3,848.259 | 6,466.067 | 1,785.763 | 2,708.751 | 3,723.174 |
| 股東權益/負債合計 (%) | 773.567 | 758.439 | 473.282 | 538.965 | 698.005 |
| 利息保障倍數 (X) | -68.614 | -35.063 | -40.342 | -17.724 | -97.835 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 48.963 | 26.850 | 26.590 | 26.496 | 27.348 |
| 存貨周轉天數 (天) | 56.512 | 51.445 | 58.365 | 62.718 | 68.424 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 15/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
